Netscientific Share Discussion Threads

[blueball] 05/3/2016 17:09

I'm a seller here.

[yasx] 03/3/2016 10:42

The seller seems to have cleared.

[yasx] 02/3/2016 21:09

A basing formation developing on the chart.

[yasx] 01/3/2016 22:40

Vortex certainly getting recognition....

[yasx] 29/2/2016 09:11

Mortimer,

Indeed - and there are likely to be many more similar deals as the offerings gains traction.

Recently , a lot of solid progress has taken place under the radar - they have reinforced most of the different limbs of the group with key operational appointments, and now we are seeing evidence of the early stage commercialisation of some of the ventures.

Looking very solid, especially when you consider that the man who reportedly cannot stop money (highly rated fund manager, Woodford) has taken nearly half the issued shares at 120p and above. If he thinks it is a stellar bet at those prices (and that was before much of the recent good news landed), then at 80p it is a jolly good bargain.

[mortimer7] 29/2/2016 09:04

RNS today, very positive news IMO:-

[yasx] 26/2/2016 20:42

hxxp://www.prnewswire.com/news-releases/wanda-to-integrate-frame-healths-personality-assessment-to-advance-consumer-engagement-and-care-plan-adherence-300225947.html

[yasx] 17/2/2016 08:53

Good appointment from a governance perspective. The change of focus over the last six months will take a while, but it ought to be fruitful.

[yasx] 09/2/2016 21:25

I have taken a few in the past few days...I reckon it might start to turn - first stop 120p.

[yasx] 09/2/2016 21:25

I have taken a few in the past few days...I reckon it might start to turn - first stop 120p.

[yasx] 09/2/2016 21:24

A positive step for PDS - but, the CEO needs to demonstrate how he hopes to crystallise value from the two core assets in terms of identifying these 'inflection' points...

[yasx] 01/2/2016 21:08

Woodford seems to be getting mauled on all his investments - there now seems little interest in acquiring the stock at below 90p even though both he and employees were happy to fill their boots at 120p.

This is thinly traded and any significant activity can lead to sharp moves in both directions.

[mortimer7] 11/11/2015 11:15

That RNS reads as if Woodfords took the vast majority of the placing shares.
Massive show of faith.

[tromso1] 11/11/2015 08:23

Big increase by Woodford to a huge 45% and he will be a long term holder so it ties up the available stock.

Price moving up from support. A good entry level here imo. A few buyers this morning in agreement.

[pennysharemillionaire2] 22/10/2015 13:49

Oh dear, I hate to say I told you so - cash burn is too big and always delays.

[samenic] 01/10/2015 17:28

He can afford to be,its other peoples money !!

[ballychan] 01/10/2015 09:19

SP always tends to drop to placing prices. Woodford is confident.

[keyno] 01/10/2015 08:54

I seem to remember reading a while ago when share price was hovering around the 200 mark that a fundraising would be required in the not too distant future - possibly it was in IC.

[hydrus] 01/10/2015 08:45

Placing is at a massive discount to a level that has fallen fairly heavily recently anyway. Not good.

[samenic] 01/10/2015 08:31

So have l got this right,sold down because one shareholder had over the 30% limit,now sold down because another shareholder wants to go over the 30% limit(allbeit at an extravagant discount).

[yasx] 01/10/2015 08:29

The proposed placing explains the recent falls...

Woodford seeking to go well beyond 30%, which will require a waiver...

[bamboo2] 15/9/2015 09:58

15 September 2015

NetScientific plc

Vortex BioSciences granted critical patent for its Liquid Biopsy technology

London, UK - 15 September 2015 - NetScientific plc ("NetScientific" or the "Group", AIM: NSCI), the transatlantic biomedical and healthcare technology group, announces that one of its key portfolio companies, Vortex BioSciences Inc., has been granted a critical patent on its core technology in the US.

Vortex BioSciences is a cancer diagnostic instrument company providing liquid biopsy solutions for isolating, detecting and harvesting circulating tumour cells ('CTC's) from cancer patients' blood sample for use in downstream clinical applications such as monitoring disease progression and drug treatment effectiveness.

The granted patent, licensed exclusively to Vortex from UCLA, was also recently issued in China and Australia and covers its core technology of inertial microfluidics and its application to the separation and collection of cells of interest including CTCs. This US patent covers the unique microfluidic chip design and performance of the Vortex assay, enabling flow of samples such as blood and collection of cells of interest via microfluidic channels and vortices. The patent also covers collection of CTCs from the chip for downstream analysis such as counting, cytology and DNA sequencing.

Dr Michael Boyce-Jacino, Head of US Operations at NetScientific: "This key patent provides strong protection of our novel and powerful new platform technology for cell separation. Alongside our three previously issued patents, this US patent strengthens our global market position as we prepare to beta launch our VTX-1 product in the US later this year."

[mortimer7] 14/9/2015 16:00

I have a notion that a trading update is due in September, but can't remember where I got that from. Anyone able to confirm please?